Survey Finds Pharma Execs Uncertain About how COVID-19 Will Affect the Volume of Business Development Efforts

Waltham, MA, June 4,
2020 — Trinity Life Sciences,
a leader in global life sciences solutions, finds that New Product Planning
(NPP) pharmaceutical executives are uncertain about how COVID-19 will affect
the volume of business development efforts. According to the new brief entitled
Impact of COVID-19 on New Product Planning, NPP teams are mixed in their
expectations for the volume of business development (BD) efforts to change in
the near term due to the COVID-19 outbreak.

“NPP teams are seeking ways to overcome delays in clinical
development and may be looking to BD as a way to fill that gap,” said Leslie
Orne, Senior Partner and Chief Client Officer at Trinity. “Some respondents
also thought depression of valuations and potential need for cash may create a
climate of more deals in the wake of COVID-19, and NPP/BD groups should be
ready to move quickly.”

The brief was based on a survey of NPP pharma leaders focusing
on how they are approaching the challenges and uncertainty caused by COVID-19. The
brief also finds that although NPP teams anticipate delays in market research
as they shift to virtual methods, they may find healthcare providers’
availability to be better than they expect, enabling them to continue critical
research and strategic decision-making in the near term.

For a full copy of Impact of COVID-19 on New Product Planning, please visit www.TrinityLifeSciences.com.

About Trinity Life Sciences

Trinity
Life Sciences is a trusted strategic partner, providing evidence-based
solutions for the life sciences. With over 20 years of experience, Trinity is
committed to solving clients’ most challenging problems through exceptional
levels of service, powerful tools, and data-driven insights. Trinity’s range of
products and solutions includes industry-leading benchmarking solutions,
powered by TGaS Advisors. To learn more about how Trinity is elevating life
sciences and driving evidence to action, visit trinitylifesciences.com.